Press Release

FDA Grants IND Approval to Base Therapeutics' Base-Edited NK Cell Therapy, Powered by GenScript's cGMP sgRNA and CytoSinct™ Platform

2024-12-06

The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development

2024-11-21

GenScript Subsidiary ProBio Instrumental in Latest Fight Against Cancer

2024-11-15

GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia

2024-11-11

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

2024-11-08

Seasoned Marketing Executive Joins GenScript as Chief Marketing Officer

2024-11-04

GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to A

2024-10-11

GenScript Appoints New Board Members to Drive Global Growth | GenScript

2024-09-12

GenScript Launches Global Philanthropy Platform: The GenTeer Program | GenScript

2024-08-19

GenScript Biotech Reports First Half 2024 Results

2024-08-09

GenScript Hosts Inaugural APAC Distributor Meeting, Strengthening Regional Partnerships for Scientific Advancements

2024-06-25

GenScript Biotech Corporation Launches FLASH Gene Service: The Fastest and Most Affordable Gene Synthesis Solution on the Market

2024-06-18

GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications

2024-05-13

GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint

2024-04-24

Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing

2024-04-23

Notice of 2024 Annual General Meeting

2024-04-22

GenScript Biotech officially joins SBTi to fulfill its sustainability commitment

2024-04-15

GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance

2024-03-26

Dr. David Liu Joins GenScript’s Scientific Advisory Board to Guide Company’s Innovation Strategy

2024-03-08

Immunotherapy Pioneer Carl H. June, MD, Joins GenScript’s Scientific Advisory Board to Guide Company’s Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs

2024-03-06